Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6349 USD | +26.90% | -8.00% | +11.39% |
May. 30 | Day One Biopharmaceuticals Sells Priority Review Voucher for $108 Million | MT |
May. 23 | Oppenheimer Adjusts Price Target on Viracta Therapeutics to $11 From $13, Maintains Outperform Rating | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- VIRX Stock
- Revisions Viracta Therapeutics, Inc.